Melanoma Institute Australia - The Poche Centre
Welcome,         Profile    Billing    Logout  
 5 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Spillane, Andrew
ACTRN12614000721606: Evaluation of Groin Lymphadenectomy Extent For metastatic Melanoma

Active, not recruiting
3
634
 
Melanoma and Skin Cancer Trial, Friends of the Mater Foundation, Cancer Council NSW, Melanoma Institute Australia
Metastatic melanoma
 
 
EAGLE FM, NCT02166788: Evaluation of Groin Lymphadenectomy Extent For Metastatic Melanoma

Active, not recruiting
3
634
Europe, RoW
Inguinal Lymphadenectomy, Ilio-inguinal Lymphadenectomy
Melanoma and Skin Cancer Trials Limited, Cancer Council New South Wales, Melanoma Institute Australia
Metastatic Melanoma to the Groin Lymph Nodes
10/19
08/30
MelMarT-II, NCT03860883: Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Recruiting
3
2998
Europe, Canada, US, RoW
Wide Local Excision = 1cm Margin, Wide Local Excision = 2cm Margin
Melanoma and Skin Cancer Trials Limited, Norfolk and Norwich University Hospitals NHS Foundation Trust, Canadian Cancer Trials Group, Cancer Trials Ireland, Zuyderland Medical Centre
Cutaneous Melanoma, Stage II
12/29
12/34
EXPERT, NCT02889874: EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer

Recruiting
N/A
1167
Europe, RoW
Omission of radiation therapy
Breast Cancer Trials, Australia and New Zealand, Breast International Group, ETOP IBCSG Partners Foundation
Early Stage Breast Carcinoma
10/25
04/26
Economides, Alex
No trials found

Download Options